253 related articles for article (PubMed ID: 8782135)
1. Presence of ED-A containing fibronectin in human articular cartilage from patients with osteoarthritis and rheumatoid arthritis.
Chevalier X; Claudepierre P; Groult N; Zardi L; Hornebeck W
J Rheumatol; 1996 Jun; 23(6):1022-30. PubMed ID: 8782135
[TBL] [Abstract][Full Text] [Related]
2. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
[TBL] [Abstract][Full Text] [Related]
3. Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage.
Di Cesare PE; Carlson CS; Stolerman ES; Hauser N; Tulli H; Paulsson M
J Orthop Res; 1996 Nov; 14(6):946-55. PubMed ID: 8982138
[TBL] [Abstract][Full Text] [Related]
4. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
5. Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluid.
Homandberg GA; Wen C; Hui F
Osteoarthritis Cartilage; 1998 Jul; 6(4):231-44. PubMed ID: 9876392
[TBL] [Abstract][Full Text] [Related]
6. Identification of fibronectin neoepitopes present in human osteoarthritic cartilage.
Zack MD; Arner EC; Anglin CP; Alston JT; Malfait AM; Tortorella MD
Arthritis Rheum; 2006 Sep; 54(9):2912-22. PubMed ID: 16948117
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin fragments in osteoarthritic synovial fluid.
Xie DL; Meyers R; Homandberg GA
J Rheumatol; 1992 Sep; 19(9):1448-52. PubMed ID: 1433014
[TBL] [Abstract][Full Text] [Related]
8. Presence and distribution of collagen II, collagen I, fibronectin, and tenascin in rabbit normal and osteoarthritic cartilage.
Pfander D; Rahmanzadeh R; Scheller EE
J Rheumatol; 1999 Feb; 26(2):386-94. PubMed ID: 9972974
[TBL] [Abstract][Full Text] [Related]
9. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
[TBL] [Abstract][Full Text] [Related]
10. Tenascin and fibronectin distribution in human normal and pathological synovium.
Cutolo M; Picasso M; Ponassi M; Sun MZ; Balza E
J Rheumatol; 1992 Sep; 19(9):1439-47. PubMed ID: 1279171
[TBL] [Abstract][Full Text] [Related]
11. Synovial fibronectin fragmentation and domain expressions in relation to rheumatoid arthritis progression.
Przybysz M; Borysewicz K; Szechinski J; Katnik-Prastowska I
Rheumatology (Oxford); 2007 Jul; 46(7):1071-5. PubMed ID: 17459959
[TBL] [Abstract][Full Text] [Related]
12. The serine protease inhibitor trappin-2 is present in cartilage and synovial fluid in osteoarthritis.
Jaovisidha K; Etim A; Yamakawa K; Masuda I; Gohr CM; Wakim BT; Boonapatcharoen N; Ninomiya J; Rosenthal AK
J Rheumatol; 2006 Feb; 33(2):318-25. PubMed ID: 16465664
[TBL] [Abstract][Full Text] [Related]
13. Citrullination of fibronectin in rheumatoid arthritis synovial tissue.
Chang X; Yamada R; Suzuki A; Kochi Y; Sawada T; Yamamoto K
Rheumatology (Oxford); 2005 Nov; 44(11):1374-82. PubMed ID: 16105911
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
[TBL] [Abstract][Full Text] [Related]
15. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
Yasuda T; Poole AR
Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
[TBL] [Abstract][Full Text] [Related]
16. High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis.
Momohara S; Okamoto H; Iwamoto T; Mizumura T; Ikari K; Kawaguchi Y; Takeuchi M; Kamatani N; Tomatsu T
J Rheumatol; 2007 Feb; 34(2):266-71. PubMed ID: 17304652
[TBL] [Abstract][Full Text] [Related]
17. Differential adherence of osteoarthritis and rheumatoid arthritis synovial fibroblasts to cartilage and bone matrix proteins and its implication for osteoarthritis pathogenesis.
Schedel J; Wenglén C; Distler O; Müller-Ladner U; Schölmerich J; Heinegård D; Krenn V
Scand J Immunol; 2004 Nov; 60(5):514-23. PubMed ID: 15541045
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of a peanut agglutinin reactive O linked oligosaccharide on fibronectins from the synovial fluid of patients with rheumatic disease: quantitation, domain localization, and functional significance.
Carsons S
J Rheumatol; 2002 May; 29(5):896-902. PubMed ID: 12022346
[TBL] [Abstract][Full Text] [Related]
19. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the Ed-B-containing fibronectin (an embryonic isoform of fibronectin) in human osteoarthritic cartilage.
Chevalier X; Groult N; Hornebeck W
Br J Rheumatol; 1996 May; 35(5):407-15. PubMed ID: 8646429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
